ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Tema Oncology ETF (NQ:CANC)

40.57 -0.61 (-1.48%)

Streaming Delayed Price Updated: 12:07 PM EDT, Jul 29, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	18,480
Open	41.05
Bid (Size)	40.44 (1,000)
Ask (Size)	40.70 (1,000)
Prev. Close	41.18
Today's Range	40.56 - 41.14
52wk Range	25.12 - 42.63
Shares Outstanding	N/A
Dividend Yield	0.05%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗

January 07, 2026

Monte Rosa Therapeutics reported positive interim Phase 1 data for MRT-8102, showing significant anti-inflammatory effects in patients with elevated cardiovascular risk.

Via Stocktwits

Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

December 02, 2025

From Tema ETFs

Via Business Wire

Performance

YTD	+17.3%	+17.3%
1 Month	-1.8%	-1.8%
3 Month	+8.8%	+8.8%
6 Month	+10.2%	+10.2%
1 Year	+51.4%	+51.4%

More News

AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK ↗

November 25, 2025

Via Stocktwits

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market ↗

April 25, 2024

Via Investor's Business Daily

Healthcare ETFs For The Weight-Loss Drug Boom And Beyond ↗

April 08, 2024

Via Talk Markets

Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too? ↗

December 05, 2023

Via Benzinga

EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads ↗

December 01, 2023

Via Benzinga

Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction ↗

November 28, 2023

Via Benzinga

Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? ↗

November 21, 2023

Via Benzinga

Frequently Asked Questions

Is Tema Oncology ETF publicly traded?

Yes, Tema Oncology ETF is publicly traded.

What exchange does Tema Oncology ETF trade on?

Tema Oncology ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Tema Oncology ETF?

The ticker symbol for Tema Oncology ETF is CANC on the Nasdaq Stock Market

What is the current price of Tema Oncology ETF?

The current price of Tema Oncology ETF is 40.57

When was Tema Oncology ETF last traded?

The last trade of Tema Oncology ETF was at 07/29/26 12:07 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.